# Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)

> **NCT02081716** · — · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 88 (actual)

## Conditions studied

- Bone Marrow Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02081716
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02081716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02081716, "Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02081716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*